Morepen Laboratories Board Meeting on Oct 27 to Approve Q2 FY27 Results

Morepen Laboratories Ltd has announced that its Board of Directors will convene on October 27, 2026, to consider and approve the un-audited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The trading window for designated persons and their immediate relatives will remain closed until 48 hours after the declaration of these financial results, extending to October 29, 2026.